Philip Desjardins, a seasoned regulator and expert in the field of medical devices, has made a return to Arnold & Porter. He will be joining as a partner in the life sciences and healthcare regulatory practice based in Washington, D.C. This development was announced by the firm on a recent Monday. Desjardins previously served as the associate director for policy at the Food and Drug Administration Center for Devices and Radiological Health. His role included aiding the FDA in the development of policies in relation to the legislation, regulations, and the enforcement actions governing medical devices.
Desjardins carries with him a significant amount of experience and expertise from his time at the FDA. There, he held substantial responsibility in crafting the regulations and guidelines that oversee the medical devices industry. The knowledge and insights gained through this experience are expected to greatly benefit his role at Arnold & Porter.
Before rejoining Arnold & Porter, Desjardins also held the position of vice president of global regulatory affairs at multinational corporation, Johnson & Johnson. His diverse professional experience strengthens his profile and makes this transition a significant event for both the firm and Desjardins personally.
His diverse career trajectory and the broad perspective he brings to his work, combined with his regulatory acumen, make him a valuable addition to Arnold & Porter’s prestigious team. The significance of his role is underscored at a time when regulatory clarity and oversight are of paramount importance in the life sciences and healthcare domains.
This development was initially reported by Bloomberg Law.